Choice of Antihypertensive Combination Therapy Based on Daily Salt Intake. (September 2015)

• Record Type: Journal Article
• Authors: Toyoda, Shigeru; Inami, Shu; Kato, Toru; Tsukada, Kinji; Nakamoto, Akiya; Kikegawa, Yoshinobu; Suzuki, Akihiro; Anraku, Yukitaka; Node, Koichi; Inoue, Teruo
• Is Part Of: American journal of the medical sciences. Volume 350:Number 3(2015)
• Publication Date: 2015-09
• Subjects: Angiotensin receptor blockers -- Thiazide diuretics -- Calcium channel blockers -- Combination pills -- Daily salt intake; Medicine -- Periodicals; Internal medicine -- Periodicals; 610.5
• DOI: 10.1097/MAJ.0000000000000529
• Languages: English
• ISSNs: 0002-9629

Abstract

Abstract: Background: It is unclear whether thiazide diuretics (TZs) or calcium channel blockers (CCBs) are more effective as add-on therapy to angiotensin receptor blockers (ARBs) in controlling hypertension. Because TZs are a rational choice in salt-sensitive hypertension, patients with high salt intake might preferentially benefit from ARB/TZ over ARB/CCB combination therapy. Methods: Hypertensive patients who failed to reach blood pressure goals despite treatment with ARBs alone were randomly assigned to receive either ARB/TZ or ARB/CCB combination therapy. Estimated daily sodium intake was calculated from spot urine values of sodium and creatinine. Results: Blood pressure was measured at baseline, and at 4, 8 and 12 weeks after starting combination therapy. For all study patients (n = 87), diastolic blood pressure reduction was greater in patients receiving ARB/CCB treatment. However, in the 37 patients with a baseline estimated daily salt intake greater than 10 g and baseline systolic blood pressure (SBP) ranging from 150 to 200 mm Hg, SBP was lower ( P < 0.05) and SBP reduction was greater ( P < 0.05) 4 weeks after starting combination therapy in those receiving ARB/TZ treatment. In the 31 patients whose estimated daily salt intake increased at 12 weeks compared with baseline, SBP at 12 weeks was lower in those receiving ARB/TZ treatment ( P < 0.05). Conclusions: Estimated daily salt intake is a useful tool for guiding antihypertensive therapy and should be measured repeatedly during the therapeutic course.